ModelEdge

20/20 GeneSystems, Inc.
0001139685
Filing Type10-K
Filing Date3/30/2026
Updated3/31/26, 3:26 PM

Filing

10-K
Earnings Release

Exhibits

10-KFY 2025
EX-3.4CERTIFICATE OF DESIGNATION OF SERIES E CONVERTIBLE PREFERRED STOCK OF 20/20 BIOLABS, INC
EX-4.1DESCRIPTION OF SECURITIES OF 20/20 BIOLABS, INC
EX-4.2WARRANT TO PURCHASE SHARES OF COMMON STOCK ISSUED BY 20/20 BIOLABS, INC. TO STREETERVILLE CAPITAL, LLC ON FEBRUARY 19, 2026
EX-4.3WARRANT TO PURCHASE SHARES OF COMMON STOCK ISSUED BY 20/20 BIOLABS, INC. TO MAXIM PARTNERS LLC ON FEBRUARY 19, 2026
EX-4.4WARRANT TO PURCHASE SHARES OF COMMON STOCK ISSUED BY 20/20 BIOLABS, INC. TO STREETERVILLE CAPITAL, LLC ON FEBRUARY 9, 2026
EX-4.5WARRANT TO PURCHASE SHARES OF COMMON STOCK ISSUED BY 20/20 BIOLABS, INC. TO MAXIM PARTNERS LLC ON FEBRUARY 9, 2026
EX-4.7WARRANT TO PURCHASE SHARES OF COMMON STOCK ISSUED BY 20/20 BIOLABS, INC. TO MAXIM PARTNERS LLC ON NOVEMBER 17, 2025
EX-10.2SECURED CONVERTIBLE PROMISSORY NOTE ISSUED BY 20/20 BIOLABS, INC. TO STREETERVILLE CAPITAL, LLC ON FEBRUARY 9, 2026
EX-14.1CODE OF BUSINESS CONDUCT AND ETHICS
EX-19.1INSIDER TRADING POLICY
EX-31.1CERTIFICATION
EX-31.2CERTIFICATION
EX-32.1CERTIFICATION
EX-32.2CERTIFICATION
EX-97.1CLAWBACK POLICY
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic